{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:07:27Z","timestamp":1793142447993,"version":"4.5.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01622-6","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:22:54Z","timestamp":1778052174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using an integrated omics approach to uncover the mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN)"],"prefix":"10.1038","volume":"6","author":[{"given":"Isabella","family":"Piga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-2946","authenticated-orcid":false,"given":"Roberta","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clizia","family":"Chinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-932X","authenticated-orcid":false,"given":"Lisa","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-4577","authenticated-orcid":false,"given":"Cristina","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"1622_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/WCO.0000000000000234","volume":"28","author":"G Cavaletti","year":"2015","unstructured":"Cavaletti, G. & Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Curr. Opin. Neurol. 28, 500\u2013507 (2015).","journal-title":"Curr. Opin. Neurol."},{"key":"1622_CR2","first-page":"913848","volume":"2012","author":"CT Pike","year":"2012","unstructured":"Pike, C. T., Birnbaum, H. G., Muehlenbein, C. E., Pohl, G. M. & Natale, R. B. Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother. Res. Pr. 2012, 913848 (2012).","journal-title":"Chemother. Res. Pr."},{"key":"1622_CR3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny, M. et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155, 2461\u20132470 (2014).","journal-title":"Pain"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41568-025-00863-2","volume":"25","author":"P Karschnia","year":"2025","unstructured":"Karschnia, P., Nelson, T. A. & Dietrich, J. Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity. Nat. Rev. Cancer 25, 887\u2013909 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"1622_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","volume":"2","author":"A Areti","year":"2014","unstructured":"Areti, A., Yerra, V. G., Naidu, V. & Kumar, A. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox Biol. 2, 289\u2013295 (2014).","journal-title":"Redox Biol."},{"key":"1622_CR6","doi-asserted-by":"publisher","first-page":"217433","DOI":"10.1016\/j.canlet.2024.217433","volume":"611","author":"Z Tao","year":"2024","unstructured":"Tao, Z., Chen, Z., Zeng, X., Cui, J. & Quan, M. An emerging aspect of cancer neuroscience: a literature review on chemotherapy-induced peripheral neuropathy. Cancer Lett. 611, 217433 (2024).","journal-title":"Cancer Lett."},{"key":"1622_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34507-3","volume":"8","author":"B Karademir","year":"2018","unstructured":"Karademir, B. et al. Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib. Sci. Rep. 8, 16318 (2018).","journal-title":"Sci. Rep."},{"key":"1622_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101502","volume":"32","author":"AT Jannuzzi","year":"2020","unstructured":"Jannuzzi, A. T. et al. Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib. Redox Biol. 32, 101502 (2020).","journal-title":"Redox Biol."},{"key":"1622_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113520","volume":"335","author":"SCL Hrstka","year":"2021","unstructured":"Hrstka, S. C. L. et al. Proteomic analysis of human iPSC-derived sensory neurons implicates cell stress and microtubule dynamics dysfunction in bortezomib-induced peripheral neurotoxicity. Exp. Neurol. 335, 113520 (2021).","journal-title":"Exp. Neurol."},{"key":"1622_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1054\/bjoc.2001.2024","volume":"85","author":"MJ McKeage","year":"2001","unstructured":"McKeage, M. J., Hsu, T., Screnci, D., Haddad, G. & Baguley, B. C. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br. J. Cancer 85, 1219\u20131225 (2001).","journal-title":"Br. J. Cancer"},{"key":"1622_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/cncr.24870","volume":"116","author":"SL Moulder","year":"2010","unstructured":"Moulder, S. L. et al. A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer. Cancer 116, 814\u2013821 (2010).","journal-title":"Cancer"},{"key":"1622_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/annonc\/mdh348","volume":"15","author":"G Cavaletti","year":"2004","unstructured":"Cavaletti, G. et al. Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Ann. Oncol. 15, 1439\u20131442 (2004).","journal-title":"Ann. Oncol."},{"key":"1622_CR13","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1158\/1078-0432.CCR-12-1590","volume":"18","author":"RM Baldwin","year":"2012","unstructured":"Baldwin, R. M. et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin. Cancer Res. 18, 5099\u20135109 (2012).","journal-title":"Clin. Cancer Res."},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","volume":"307","author":"C Meregalli","year":"2018","unstructured":"Meregalli, C. et al. Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy. Exp. Neurol. 307, 129\u2013132 (2018).","journal-title":"Exp. Neurol."},{"key":"1622_CR15","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s00204-020-02755-w","volume":"94","author":"C Meregalli","year":"2020","unstructured":"Meregalli, C. et al. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of chemotherapy-induced peripheral neurotoxicity. Arch. Toxicol. 94, 2517\u20132522 (2020).","journal-title":"Arch. Toxicol."},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/jns.12493","volume":"27","author":"S Karteri","year":"2022","unstructured":"Karteri, S. et al. Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients. J. Peripher Nerv. Syst. 27, 166\u2013174 (2022).","journal-title":"J. Peripher Nerv. Syst."},{"key":"1622_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5302-4","volume":"19","author":"A Molassiotis","year":"2019","unstructured":"Molassiotis, A. et al. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer 19, 132 (2019).","journal-title":"BMC Cancer"},{"key":"1622_CR18","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.neurol.2020.11.001","volume":"177","author":"R Bonomo","year":"2021","unstructured":"Bonomo, R. & Cavaletti, G. Clinical and biochemical markers in CIPN: a reappraisal. Rev. Neurol. 177, 890\u2013907 (2021).","journal-title":"Rev. Neurol."},{"key":"1622_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36014-0","volume":"14","author":"M Jung","year":"2023","unstructured":"Jung, M. et al. Cross-species transcriptomic atlas of dorsal root ganglia reveals species-specific programs for sensory function. Nat. Commun. 14, 366 (2023).","journal-title":"Nat. Commun."},{"key":"1622_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nmeth.1315","volume":"6","author":"F Tang","year":"2009","unstructured":"Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377\u2013382 (2009).","journal-title":"Nat. Methods"},{"key":"1622_CR21","doi-asserted-by":"publisher","first-page":"eadj9173","DOI":"10.1126\/sciadv.adj9173","volume":"10","author":"SA Bhuiyan","year":"2024","unstructured":"Bhuiyan, S. A. et al. Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia. Sci. Adv. 10, eadj9173 (2024).","journal-title":"Sci. Adv."},{"key":"1622_CR22","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1016\/j.cell.2024.10.023","volume":"187","author":"T Lu","year":"2024","unstructured":"Lu, T. et al. Decoding transcriptional identity in developing human sensory neurons and organoid modeling. Cell 187, 7374\u20137393.e28 (2024).","journal-title":"Cell"},{"key":"1622_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature13173","volume":"509","author":"B Treutlein","year":"2014","unstructured":"Treutlein, B. et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature 509, 371\u2013375 (2014).","journal-title":"Nature"},{"key":"1622_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum, A. I., Bautista, D. M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267\u2013284 (2009).","journal-title":"Cell"},{"key":"1622_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.3881","volume":"18","author":"D Usoskin","year":"2015","unstructured":"Usoskin, D. et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat. Neurosci. 18, 145\u2013153 (2015).","journal-title":"Nat. Neurosci."},{"key":"1622_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1900-1","volume":"577","author":"N Sharma","year":"2020","unstructured":"Sharma, N. et al. The emergence of transcriptional identity in somatosensory neurons. Nature 577, 392\u2013398 (2020).","journal-title":"Nature"},{"key":"1622_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21725-z","volume":"12","author":"J Kupari","year":"2021","unstructured":"Kupari, J. et al. Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain. Nat. Commun. 12, 1510 (2021).","journal-title":"Nat. Commun."},{"key":"1622_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj8186","volume":"14","author":"D Tavares-Ferreira","year":"2022","unstructured":"Tavares-Ferreira, D. et al. Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors. Sci. Transl. Med. 14, eabj8186 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1622_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/brain\/awac266","volume":"146","author":"PR Ray","year":"2023","unstructured":"Ray, P. R. et al. RNA profiling of human dorsal root ganglia reveals sex differences in mechanisms promoting neuropathic pain. Brain 146, 749\u2013766 (2023).","journal-title":"Brain"},{"key":"1622_CR30","doi-asserted-by":"crossref","unstructured":"Nguyen, M. Q., von Buchholtz, L. J., Reker, A. N., Ryba, N. J. & Davidson, S. Single-nucleus transcriptomic analysis of human dorsal root ganglion neurons. Elife 10, e71752 (2021).","DOI":"10.7554\/eLife.71752"},{"key":"1622_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/srep31851","volume":"6","author":"G Hu","year":"2016","unstructured":"Hu, G. et al. Single-cell RNA-seq reveals distinct injury responses in different types of DRG sensory neurons. Sci. Rep. 6, 31851 (2016).","journal-title":"Sci. Rep."},{"key":"1622_CR32","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/j.pain.0000000000003120","volume":"165","author":"DS George","year":"2024","unstructured":"George, D. S. et al. The Mas-related G protein-coupled receptor d (Mrgprd) mediates pain hypersensitivity in painful diabetic neuropathy. Pain 165, 1154\u20131168 (2024).","journal-title":"Pain"},{"key":"1622_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jpain.2019.06.008","volume":"21","author":"H Starobova","year":"2020","unstructured":"Starobova, H., Mueller, A., Deuis, J. R., Carter, D. A. & Vetter, I. Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin, and oxaliplatin in C57BL\/6J mice. J. Pain. 21, 182\u2013194 (2020).","journal-title":"J. Pain."},{"key":"1622_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/17448069221106167","volume":"19","author":"W Sun","year":"2023","unstructured":"Sun, W. et al. Transcriptome analysis reveals dysregulation of inflammatory and neuronal function in dorsal root ganglion of paclitaxel-induced peripheral neuropathy rats. Mol. Pain. 19, 17448069221106167 (2023).","journal-title":"Mol. Pain."},{"key":"1622_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2023.02.007","volume":"516","author":"W Sun","year":"2023","unstructured":"Sun, W. et al. Comparative transcriptome of dorsal root ganglia reveals distinct etiologies of paclitaxel- and oxaliplatin-induced peripheral neuropathy in rats. Neuroscience 516, 1\u201314 (2023).","journal-title":"Neuroscience"},{"key":"1622_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"1622_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nrg2934","volume":"12","author":"F Ozsolak","year":"2011","unstructured":"Ozsolak, F. & Milos, P. M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12, 87\u201398 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"1622_CR38","doi-asserted-by":"crossref","unstructured":"Shukla, S. et al. Development of a RNA-seq based prognostic signature in lung adenocarcinoma. J. Natl. Cancer Inst. 109, djw200 (2017).","DOI":"10.1093\/jnci\/djw200"},{"key":"1622_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/cam4.1397","volume":"7","author":"L-O Han","year":"2018","unstructured":"Han, L.-O., Li, X.-Y., Cao, M.-M., Cao, Y. & Zhou, L.-H. Development and validation of an individualized diagnostic signature in thyroid cancer. Cancer Med. 7, 1135\u20131140 (2018).","journal-title":"Cancer Med."},{"key":"1622_CR40","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3389\/fonc.2019.01361","volume":"9","author":"J-G Zhou","year":"2019","unstructured":"Zhou, J.-G. et al. Development and validation of an RNA-seq-based prognostic signature in neuroblastoma. Front. Oncol. 9, 1361 (2019).","journal-title":"Front. Oncol."},{"key":"1622_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.copbio.2019.03.001","volume":"58","author":"A Kulkarni","year":"2019","unstructured":"Kulkarni, A., Anderson, A. G., Merullo, D. P. & Konopka, G. Beyond bulk: a review of single cell transcriptomics methodologies and applications. Curr. Opin. Biotechnol. 58, 129\u2013136 (2019).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1622_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/neuonc\/noaa151","volume":"23","author":"A Calls","year":"2021","unstructured":"Calls, A. et al. Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response. Neuro Oncol. 23, 88\u201399 (2021).","journal-title":"Neuro Oncol."},{"key":"1622_CR43","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1002\/acn3.51691","volume":"9","author":"A Calls","year":"2022","unstructured":"Calls, A. et al. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice. Ann. Clin. Transl. Neurol. 9, 1985\u20131998 (2022).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1622_CR44","doi-asserted-by":"crossref","unstructured":"Sun, W. et al. Single-nucleus rna sequencing identifies universal camk1d upregulation and dysregulated c-ltmr subtypes as key drivers of paclitaxel-induced neuropathy. Cell Biol Toxicol. 41, 114 (2025).","DOI":"10.1007\/s10565-025-10065-z"},{"key":"1622_CR45","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Contribution of S1pr1 -featured astrocyte subpopulation to cisplatin-induced neuropathic pain in male mice. Pain. 167, 204\u2013217 (2026).","DOI":"10.1097\/j.pain.0000000000003780"},{"key":"1622_CR46","doi-asserted-by":"publisher","first-page":"e1009968","DOI":"10.1371\/journal.pgen.1009968","volume":"18","author":"GM Cunningham","year":"2022","unstructured":"Cunningham, G. M. et al. The impact of SBF2 on taxane-induced peripheral neuropathy. PLoS Genet. 18, e1009968 (2022).","journal-title":"PLoS Genet."},{"key":"1622_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/hmg\/ddg030","volume":"12","author":"J Senderek","year":"2003","unstructured":"Senderek, J. et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2\/11p15. Hum. Mol. Genet. 12, 349\u2013356 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"1622_CR48","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1212\/01.WNL.0000140617.02312.80","volume":"63","author":"FL Conforti","year":"2004","unstructured":"Conforti, F. L. et al. A new SBF2 mutation in a family with recessive demyelinating Charcot-Marie-Tooth (CMT4B2). Neurology 63, 1327\u20131328 (2004).","journal-title":"Neurology"},{"key":"1622_CR49","doi-asserted-by":"publisher","first-page":"82244","DOI":"10.18632\/oncotarget.12545","volume":"7","author":"BP Schneider","year":"2016","unstructured":"Schneider, B. P. et al. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans. Oncotarget 7, 82244\u201382253 (2016).","journal-title":"Oncotarget"},{"key":"1622_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03754-4","volume":"20","author":"K Hooshmand","year":"2022","unstructured":"Hooshmand, K. et al. Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study. J. Transl. Med. 20, 564 (2022).","journal-title":"J. Transl. Med."},{"key":"1622_CR51","first-page":"362","volume":"33","author":"MK Jones","year":"2025","unstructured":"Jones, M. K. et al. Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. Support Care Cancer 33, 362 (2025).","journal-title":"Support Care Cancer"},{"key":"1622_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41576-019-0129-z","volume":"20","author":"DJ Burgess","year":"2019","unstructured":"Burgess, D. J. Spatial transcriptomics coming of age. Nat. Rev. Genet. 20, 317 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"1622_CR53","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41592-022-01409-2","volume":"19","author":"L Moses","year":"2022","unstructured":"Moses, L. & Pachter, L. Museum of spatial transcriptomics. Nat. Methods 19, 534\u2013546 (2022).","journal-title":"Nat. Methods"},{"key":"1622_CR54","doi-asserted-by":"publisher","first-page":"136087","DOI":"10.1016\/j.neulet.2021.136087","volume":"760","author":"TM Doyle","year":"2021","unstructured":"Doyle, T. M. & Salvemini, D. Mini-review: mitochondrial dysfunction and chemotherapy-induced neuropathic pain. Neurosci. Lett. 760, 136087 (2021).","journal-title":"Neurosci. Lett."},{"key":"1622_CR55","doi-asserted-by":"publisher","first-page":"116070","DOI":"10.1016\/j.bcp.2024.116070","volume":"222","author":"J Ollodart","year":"2024","unstructured":"Ollodart, J., Steele, L. R., Romero-Sandoval, E. A., Strowd, R. E. & Shiozawa, Y. Contributions of neuroimmune interactions to chemotherapy-induced peripheral neuropathy development and its prevention\/therapy. Biochem. Pharm. 222, 116070 (2024).","journal-title":"Biochem. Pharm."},{"key":"1622_CR56","doi-asserted-by":"publisher","first-page":"647451","DOI":"10.3389\/fnmol.2021.647451","volume":"14","author":"E Fingleton","year":"2021","unstructured":"Fingleton, E., Li, Y. & Roche, K. W. Advances in proteomics allow insights into neuronal proteomes. Front. Mol. Neurosci. 14, 647451 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"1622_CR57","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","volume":"55","author":"B Aslam","year":"2017","unstructured":"Aslam, B., Basit, M., Nisar, M. A., Khurshid, M. & Rasool, M. H. Proteomics: technologies and their applications. J. Chromatogr. Sci. 55, 182\u2013196 (2017).","journal-title":"J. Chromatogr. Sci."},{"key":"1622_CR58","doi-asserted-by":"publisher","first-page":"e2300512","DOI":"10.1002\/jssc.202300512","volume":"46","author":"S Perchepied","year":"2023","unstructured":"Perchepied, S., Zhou, Z., Mitulovi\u0107, G. & Eeltink, S. Exploiting ion-mobility mass spectrometry for unraveling proteome complexity. J. Sep Sci. 46, e2300512 (2023).","journal-title":"J. Sep Sci."},{"key":"1622_CR59","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/acs.jproteome.4c00248","volume":"23","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. et al. The future of proteomics is up in the air: can ion mobility replace liquid chromatography for high throughput proteomics? J. Proteome Res. 23, 1871\u20131882 (2024).","journal-title":"J. Proteome Res."},{"key":"1622_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-0716-1024-4_8","volume":"2228","author":"S Rozanova","year":"2021","unstructured":"Rozanova, S. et al. Quantitative mass spectrometry-based proteomics: an overview. Methods Mol. Biol. 2228, 85\u2013116 (2021).","journal-title":"Methods Mol. Biol."},{"key":"1622_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1039\/D0MO00072H","volume":"17","author":"L Krasny","year":"2021","unstructured":"Krasny, L. & Huang, P. H. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol. Omics 17, 29\u201342 (2021).","journal-title":"Mol. Omics"},{"key":"1622_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14789450.2023.2265062","volume":"20","author":"S Mehta","year":"2023","unstructured":"Mehta, S. et al. A galaxy of informatics resources for MS-based proteomics. Expert Rev. Proteom. 20, 251\u2013266 (2023).","journal-title":"Expert Rev. Proteom."},{"key":"1622_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201800088","volume":"13","author":"A Vlahou","year":"2019","unstructured":"Vlahou, A. Implementation of clinical proteomics: a step closer to personalized medicine? Proteom. Clin. Appl. 13, e1800088 (2019).","journal-title":"Proteom. Clin. Appl."},{"key":"1622_CR64","doi-asserted-by":"publisher","first-page":"e0145816","DOI":"10.1371\/journal.pone.0145816","volume":"10","author":"EI Chen","year":"2015","unstructured":"Chen, E. I. et al. Identifying predictors of taxane-induced peripheral neuropathy using mass spectrometry-based proteomics technology. PLoS ONE 10, e0145816 (2015).","journal-title":"PLoS ONE"},{"key":"1622_CR65","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00380","volume":"9","author":"N Nguyen-Hoang","year":"2025","unstructured":"Nguyen-Hoang, N. et al. Quantitation of plasma proteins to predict taxane-induced peripheral neuropathy. JCO Precis Oncol. 9, e2400380 (2025).","journal-title":"JCO Precis Oncol."},{"key":"1622_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.818690","volume":"13","author":"L de Clauser","year":"2022","unstructured":"de Clauser, L. et al. Proteome and network analysis provides novel insights into developing and established chemotherapy-induced peripheral neuropathy. Front. Pharm. 13, 818690 (2022).","journal-title":"Front. Pharm."},{"key":"1622_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306498","volume":"19","author":"R Hanna","year":"2024","unstructured":"Hanna, R. et al. Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic pain. PLoS ONE 19, e0306498 (2024).","journal-title":"PLoS ONE"},{"key":"1622_CR68","doi-asserted-by":"crossref","unstructured":"Liu, C. -H. et al. Nodal \u03b2 spectrins are required to maintain Na channel clustering and axon integrity. Elife 9, e52378 (2020).","DOI":"10.7554\/eLife.52378"},{"key":"1622_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jare.2024.03.006","volume":"68","author":"Y Zou","year":"2025","unstructured":"Zou, Y. et al. Sonic hedgehog restrains the ubiquitin-dependent degradation of SP1 to inhibit neuronal\/glial senescence associated phenotypes in chemotherapy-induced peripheral neuropathy via the TRIM25-CXCL13 axis. J. Adv. Res. 68, 387\u2013402 (2025).","journal-title":"J. Adv. Res."},{"key":"1622_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2024.01.335","volume":"25","author":"G Warren","year":"2024","unstructured":"Warren, G. et al. Discovery and preclinical evaluation of a novel inhibitor of FABP5, ART26.12, effective in oxaliplatin-induced peripheral neuropathy. J. Pain. 25, 104470 (2024).","journal-title":"J. Pain."},{"key":"1622_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107491","volume":"148","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Chemical sensors detect and resolve proteome aggregation in peripheral neuropathy cell model induced by chemotherapeutic agents. Bioorg. Chem. 148, 107491 (2024).","journal-title":"Bioorg. Chem."},{"key":"1622_CR72","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess, J. et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol. Ther. 9, 385\u2013450 (2021).","journal-title":"Oncol. Ther."},{"key":"1622_CR73","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3389\/fimmu.2019.02534","volume":"10","author":"ME Ijsselsteijn","year":"2019","unstructured":"Ijsselsteijn, M. E., van der Breggen, R., Farina Sarasqueta, A., Koning, F. & de Miranda, N. F. C. C. A 40-marker panel for high dimensional characterization of cancer immune microenvironments by imaging mass cytometry. Front. Immunol. 10, 2534 (2019).","journal-title":"Front. Immunol."},{"key":"1622_CR74","doi-asserted-by":"crossref","unstructured":"Djambazova, K. V., van Ardenne, J. M. & Spraggins, J. M. Advances in imaging mass spectrometry for biomedical and clinical research. Trends Analyt. Chem. 169, 117344 (2023).","DOI":"10.1016\/j.trac.2023.117344"},{"key":"1622_CR75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/1873-3468.14795","volume":"598","author":"I Piga","year":"2024","unstructured":"Piga, I., Magni, F. & Smith, A. The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations. FEBS Lett. 598, 621\u2013634 (2024).","journal-title":"FEBS Lett."},{"key":"1622_CR76","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1021\/acs.jproteome.2c00601","volume":"21","author":"V Denti","year":"2022","unstructured":"Denti, V. et al. Spatial multiomics of lipids, N-glycans, and tryptic peptides on a single FFPE tissue section. J. Proteome Res. 21, 2798\u20132809 (2022).","journal-title":"J. Proteome Res."},{"key":"1622_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1182404","volume":"11","author":"MJ Lim","year":"2023","unstructured":"Lim, M. J. et al. MALDI HiPLEX-IHC: multiomic and multimodal imaging of targeted intact proteins in tissues. Front. Chem. 11, 1182404 (2023).","journal-title":"Front. Chem."},{"key":"1622_CR78","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1002\/pmic.200800127","volume":"8","author":"EB Monroe","year":"2008","unstructured":"Monroe, E. B. et al. SIMS and MALDI MS imaging of the spinal cord. Proteomics 8, 3746\u20133754 (2008).","journal-title":"Proteomics"},{"key":"1622_CR79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/1469066717703272","volume":"23","author":"P Sui","year":"2017","unstructured":"Sui, P. et al. Neuropeptide imaging in rat spinal cord with MALDI-TOF MS: Method development for the application in pain-related disease studies. Eur. J. Mass Spectrom. 23, 105\u2013115 (2017).","journal-title":"Eur. J. Mass Spectrom."},{"key":"1622_CR80","doi-asserted-by":"publisher","first-page":"114255","DOI":"10.1016\/j.bcp.2020.114255","volume":"182","author":"FF Caputi","year":"2020","unstructured":"Caputi, F. F. et al. The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms. Biochem. Pharmacol. 182, 114255 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"1622_CR81","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00213-020-05572-2","volume":"237","author":"JA Meade","year":"2020","unstructured":"Meade, J. A. et al. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy. Psychopharmacology 237, 2777\u20132793 (2020).","journal-title":"Psychopharmacology"},{"key":"1622_CR82","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1124\/jpet.110.175976","volume":"337","author":"Y Tatsushima","year":"2011","unstructured":"Tatsushima, Y. et al. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. J. Pharmacol. Exp. Ther. 337, 226\u2013235 (2011).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1622_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2015.11.055","volume":"770","author":"T Chiba","year":"2016","unstructured":"Chiba, T. et al. Paclitaxel-induced peripheral neuropathy increases substance P release in rat spinal cord. Eur. J. Pharmacol. 770, 46\u201351 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"1622_CR84","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/WNR.0000000000001199","volume":"30","author":"Y Wu","year":"2019","unstructured":"Wu, Y., Chen, J. & Wang, R. Puerarin suppresses TRPV1, calcitonin gene-related peptide and substance P to prevent paclitaxel-induced peripheral neuropathic pain in rats. Neuroreport 30, 288\u2013294 (2019).","journal-title":"Neuroreport"},{"key":"1622_CR85","doi-asserted-by":"publisher","first-page":"136512","DOI":"10.1016\/j.neulet.2022.136512","volume":"773","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain. Neurosci. Lett. 773, 136512 (2022).","journal-title":"Neurosci. Lett."},{"key":"1622_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11011-023-01315-2","volume":"39","author":"Akhilesh","year":"2024","unstructured":"Akhilesh, Uniyal, A., Mehta, A. & Tiwari, V. Combination chemotherapy in rodents: a model for chemotherapy-induced neuropathic pain and pharmacological screening. Metab. Brain Dis. 39, 43\u201365 (2024).","journal-title":"Metab. Brain Dis."},{"key":"1622_CR87","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2018.12.035","volume":"698","author":"Y Mihara","year":"2019","unstructured":"Mihara, Y. et al. Lysophosphatidic acid precursor levels decrease and an arachidonic acid-containing phosphatidylcholine level increases in the dorsal root ganglion of mice after peripheral nerve injury. Neurosci. Lett. 698, 69\u201375 (2019).","journal-title":"Neurosci. Lett."},{"key":"1622_CR88","doi-asserted-by":"publisher","first-page":"e0177595","DOI":"10.1371\/journal.pone.0177595","volume":"12","author":"T Banno","year":"2017","unstructured":"Banno, T. et al. Arachidonic acid containing phosphatidylcholine increases due to microglial activation in ipsilateral spinal dorsal horn following spared sciatic nerve injury. PLoS ONE 12, e0177595 (2017).","journal-title":"PLoS ONE"},{"key":"1622_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/srep26427","volume":"6","author":"D Xu","year":"2016","unstructured":"Xu, D. et al. Increased arachidonic acid-containing phosphatidylcholine is associated with reactive microglia and astrocytes in the spinal cord after peripheral nerve injury. Sci. Rep. 6, 26427 (2016).","journal-title":"Sci. Rep."},{"key":"1622_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52999-5","volume":"9","author":"B Uranbileg","year":"2019","unstructured":"Uranbileg, B. et al. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: a study using a rat cauda equina compression model. Sci. Rep. 9, 16578 (2019).","journal-title":"Sci. Rep."},{"key":"1622_CR91","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/joa.13909","volume":"243","author":"D Tomalty","year":"2023","unstructured":"Tomalty, D. et al. Molecular characterization of human peripheral nerves using desorption electrospray ionization mass spectrometry imaging. J. Anat. 243, 758\u2013769 (2023).","journal-title":"J. Anat."},{"key":"1622_CR92","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/acschemneuro.6b00010","volume":"7","author":"R Fern\u00e1ndez","year":"2016","unstructured":"Fern\u00e1ndez, R. et al. Deciphering the lipid architecture of the rat sciatic nerve using imaging mass spectrometry. ACS Chem. Neurosci. 7, 624\u2013632 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"1622_CR93","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s13361-015-1128-8","volume":"26","author":"SS Rubakhin","year":"2015","unstructured":"Rubakhin, S. S., Ulanov, A. & Sweedler, J. V. Mass spectrometry imaging and GC-MS profiling of the mammalian peripheral sensory-motor circuit. J. Am. Soc. Mass Spectrom. 26, 958\u2013966 (2015).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"1622_CR94","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.talanta.2016.11.026","volume":"164","author":"E Moreno-Gordaliza","year":"2017","unstructured":"Moreno-Gordaliza, E. et al. MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy. Talanta 164, 16\u201326 (2017).","journal-title":"Talanta"},{"key":"1622_CR95","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00280-019-03956-6","volume":"84","author":"Y Cao","year":"2019","unstructured":"Cao, Y. et al. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy. Cancer Chemother. Pharmacol. 84, 1195\u20131200 (2019).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1622_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.122915","volume":"237","author":"J Ferey","year":"2022","unstructured":"Ferey, J. et al. Imaging matrix-assisted laser desorption\/ionization fourier transform ion cyclotron resonance mass spectrometry of oxaliplatin derivatives in human tissue sections. Talanta 237, 122915 (2022).","journal-title":"Talanta"},{"key":"1622_CR97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1515\/pp-2020-0149","volume":"6","author":"M Larroque","year":"2021","unstructured":"Larroque, M. et al. Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging. Pleura Peritoneum 6, 67\u201374 (2021).","journal-title":"Pleura Peritoneum"},{"key":"1622_CR98","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/rcm.4408","volume":"24","author":"A Bouslimani","year":"2010","unstructured":"Bouslimani, A., Bec, N., Glueckmann, M., Hirtz, C. & Larroque, C. Matrix-assisted laser desorption\/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Commun. Mass Spectrom. 24, 415\u2013421 (2010).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"1622_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/srep38507","volume":"6","author":"X Liu","year":"2016","unstructured":"Liu, X. & Hummon, A. B. Chemical imaging of platinum-based drugs and their metabolites. Sci. Rep. 6, 38507 (2016).","journal-title":"Sci. Rep."},{"key":"1622_CR100","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/4551054a","volume":"455","author":"JK Nicholson","year":"2008","unstructured":"Nicholson, J. K. & Lindon, J. C. Systems biology: metabonomics. Nature 455, 1054\u20131056 (2008).","journal-title":"Nature"},{"key":"1622_CR101","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","volume":"27","author":"AC Schrimpe-Rutledge","year":"2016","unstructured":"Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D. & McLean, J. A. Untargeted metabolomics strategies-challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27, 1897\u20131905 (2016).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"1622_CR102","doi-asserted-by":"crossref","unstructured":"Emwas, A.-H. et al. NMR spectroscopy for metabolomics research. Metabolites 9, 123 (2019).","DOI":"10.3390\/metabo9070123"},{"key":"1622_CR103","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060\u20131083 (2011).","journal-title":"Nat. Protoc."},{"key":"1622_CR104","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-016-1108-4","volume":"12","author":"DB Kell","year":"2016","unstructured":"Kell, D. B. & Oliver, S. G. The metabolome 18 years on: a concept comes of age. Metabolomics 12, 148 (2016).","journal-title":"Metabolomics"},{"key":"1622_CR105","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1622_CR106","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrm2934","volume":"11","author":"A Shevchenko","year":"2010","unstructured":"Shevchenko, A. & Simons, K. Lipidomics: coming to grips with lipid diversity. Nat. Rev. Mol. Cell Biol. 11, 593\u2013598 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1622_CR107","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov. 15, 473\u2013484 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1622_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pbb.2013.03.002","volume":"106","author":"H-Y Wang","year":"2013","unstructured":"Wang, H.-Y., Tsai, Y.-J., Chen, S.-H., Lin, C.-T. & Lue, J.-H. Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus. Pharm. Biochem. Behav. 106, 47\u201356 (2013).","journal-title":"Pharm. Biochem. Behav."},{"key":"1622_CR109","doi-asserted-by":"publisher","first-page":"12544","DOI":"10.1073\/pnas.1613246113","volume":"113","author":"M Sisignano","year":"2016","unstructured":"Sisignano, M. et al. Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain. Proc. Natl. Acad. Sci. USA 113, 12544\u201312549 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1622_CR110","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fphar.2018.00956","volume":"9","author":"F-Z Wu","year":"2018","unstructured":"Wu, F.-Z. et al. Wen-Luo-Tong decoction attenuates paclitaxel-induced peripheral neuropathy by regulating linoleic acid and glycerophospholipid metabolism pathways. Front. Pharm. 9, 956 (2018).","journal-title":"Front. Pharm."},{"key":"1622_CR111","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1074\/jbc.M114.569574","volume":"289","author":"K Janes","year":"2014","unstructured":"Janes, K. et al. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. J. Biol. Chem. 289, 21082\u201321097 (2014).","journal-title":"J. Biol. Chem."},{"key":"1622_CR112","first-page":"e73784","volume":"16","author":"C Li","year":"2024","unstructured":"Li, C., Yamamoto, T., Kanemaru, H., Kishimoto, N. & Seo, K. Effects of sphingosine-1-phosphate on the facilitation of peripheral nerve regeneration. Cureus 16, e73784 (2024).","journal-title":"Cureus"},{"key":"1622_CR113","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1074\/jbc.M311743200","volume":"279","author":"MG Sanna","year":"2004","unstructured":"Sanna, M. G. et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279, 13839\u201313848 (2004).","journal-title":"J. Biol. Chem."},{"key":"1622_CR114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","volume":"1831","author":"JW Choi","year":"2013","unstructured":"Choi, J. W. & Chun, J. Lysophospholipids and their receptors in the central nervous system. Biochim Biophys. Acta 1831, 20\u201332 (2013).","journal-title":"Biochim Biophys. Acta"},{"key":"1622_CR115","first-page":"1","volume":"28","author":"Shota Yamamoto and Nobuaki Egashira","year":"2021","unstructured":"Shota Yamamoto and Nobuaki Egashira Lipid signaling in chemotherapy-induced peripheral neuropathy. Curr. Opin. Toxicol. 28, 1\u20136 (2021).","journal-title":"Curr. Opin. Toxicol."},{"key":"1622_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka, M., Harikumar, K. B., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22, 50\u201360 (2012).","journal-title":"Trends Cell Biol."},{"key":"1622_CR117","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1194\/jlr.R046300","volume":"55","author":"VA Blaho","year":"2014","unstructured":"Blaho, V. A. & Hla, T. An update on the biology of sphingosine 1-phosphate receptors. J. Lipid Res. 55, 1596\u20131608 (2014).","journal-title":"J. Lipid Res."},{"key":"1622_CR118","doi-asserted-by":"publisher","first-page":"1407347","DOI":"10.3389\/fphar.2024.1407347","volume":"15","author":"D Dong","year":"2024","unstructured":"Dong, D., Yu, X., Tao, X., Wang, Q. & Zhao, L. S1P\/S1PR1 signaling is involved in the development of nociceptive pain. Front. Pharm. 15, 1407347 (2024).","journal-title":"Front. Pharm."},{"key":"1622_CR119","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1084\/jem.20170584","volume":"215","author":"K Stockstill","year":"2018","unstructured":"Stockstill, K. et al. Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain. J. Exp. Med. 215, 1301\u20131313 (2018).","journal-title":"J. Exp. Med."},{"key":"1622_CR120","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0021-9258(17)49922-4","volume":"295","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy. J. Biol. Chem. 295, 1143\u20131152 (2020).","journal-title":"J. Biol. Chem."},{"key":"1622_CR121","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1096\/fj.15-272567","volume":"29","author":"R Kramer","year":"2015","unstructured":"Kramer, R. et al. Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy. FASEB J. 29, 4461\u20134472 (2015).","journal-title":"FASEB J."},{"key":"1622_CR122","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/jnc.14985","volume":"154","author":"KA Becker","year":"2020","unstructured":"Becker, K. A. et al. Role of 1-Deoxysphingolipids in docetaxel neurotoxicity. J. Neurochem. 154, 662\u2013672 (2020).","journal-title":"J. Neurochem."},{"key":"1622_CR123","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jns.12609","volume":"29","author":"R Bonomo","year":"2024","unstructured":"Bonomo, R. et al. Effect of age on metabolomic changes in a model of paclitaxel-induced peripheral neurotoxicity. J. Peripher. Nerv. Syst. 29, 58\u201371 (2024).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"1622_CR124","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1111\/cas.14178","volume":"110","author":"K Maekawa","year":"2019","unstructured":"Maekawa, K. et al. Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma. Cancer Sci. 110, 3267\u20133274 (2019).","journal-title":"Cancer Sci."},{"key":"1622_CR125","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10549-018-4862-3","volume":"171","author":"Y Sun","year":"2018","unstructured":"Sun, Y. et al. Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy. Breast Cancer Res. Treat. 171, 657\u2013666 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"1622_CR126","doi-asserted-by":"publisher","unstructured":"Chen, C. -S. et al. Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-3242513\/v1 (2023).","DOI":"10.21203\/rs.3.rs-3242513\/v1"},{"key":"1622_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66815-y","volume":"10","author":"P Verma","year":"2020","unstructured":"Verma, P. et al. A metabolomics approach for early prediction of vincristine-induced peripheral neuropathy. Sci. Rep. 10, 9659 (2020).","journal-title":"Sci. Rep."},{"key":"1622_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113386","volume":"42","author":"S Zhong","year":"2023","unstructured":"Zhong, S. et al. Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid. Cell Rep. 42, 113386 (2023).","journal-title":"Cell Rep."},{"key":"1622_CR129","doi-asserted-by":"publisher","first-page":"116492","DOI":"10.1016\/j.jpba.2024.116492","volume":"252","author":"Y Hua","year":"2025","unstructured":"Hua, Y., Lv, J., Zhang, Y., Ding, Y. & Chen, J. LC-MS-based serum metabolomics analysis and potential biomarkers for oxaliplatin induced neurotoxicity in colorectal cancer. J. Pharm. Biomed. Anal. 252, 116492 (2025).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"1622_CR130","doi-asserted-by":"publisher","first-page":"153303382211271","DOI":"10.1177\/15330338221127169","volume":"21","author":"A Sharma","year":"2022","unstructured":"Sharma, A. et al. A multimodal approach to discover biomarkers for taxane-induced peripheral neuropathy (TIPN): a study protocol. Technol. Cancer Res. Treat. 21, 15330338221127169 (2022).","journal-title":"Technol. Cancer Res. Treat."},{"key":"1622_CR131","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. The potential antinociceptive effect and mechanism of Cannabis sativa L. extract on paclitaxel-induced neuropathic pain in rats uncovered by multi-omics analysis. Molecules 29, 1958 (2024).","DOI":"10.3390\/molecules29091958"},{"key":"1622_CR132","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","volume":"160","author":"LA Colvin","year":"2019","unstructured":"Colvin, L. A. Chemotherapy-induced peripheral neuropathy: where are we now? Pain 160, S1\u2013S10 (2019).","journal-title":"Pain"},{"key":"1622_CR133","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jpainsymman.2018.08.017","volume":"56","author":"KM Kober","year":"2018","unstructured":"Kober, K. M. et al. Phenotypic characterization of paclitaxel-induced peripheral neuropathy in cancer survivors. J. Pain. Symptom Manag. 56, 908\u2013919.e3 (2018).","journal-title":"J. Pain. Symptom Manag."},{"key":"1622_CR134","doi-asserted-by":"publisher","first-page":"e0221787","DOI":"10.1371\/journal.pone.0221787","volume":"14","author":"S Gadgil","year":"2019","unstructured":"Gadgil, S. et al. A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN). PLoS ONE 14, e0221787 (2019).","journal-title":"PLoS ONE"},{"key":"1622_CR135","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/03007995.2017.1284051","volume":"33","author":"M Cascella","year":"2017","unstructured":"Cascella, M. Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research. Curr. Med. Res. Opin. 33, 981\u2013984 (2017).","journal-title":"Curr. Med. Res. Opin."},{"key":"1622_CR136","doi-asserted-by":"publisher","first-page":"e3000243","DOI":"10.1371\/journal.pbio.3000243","volume":"17","author":"GL Currie","year":"2019","unstructured":"Currie, G. L. et al. Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis. PLoS Biol. 17, e3000243 (2019).","journal-title":"PLoS Biol."},{"key":"1622_CR137","doi-asserted-by":"publisher","first-page":"113140","DOI":"10.1016\/j.expneurol.2019.113140","volume":"326","author":"HC Lehmann","year":"2020","unstructured":"Lehmann, H. C., Staff, N. P. & Hoke, A. Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: prospects and limitations. Exp. Neurol. 326, 113140 (2020).","journal-title":"Exp. Neurol."},{"key":"1622_CR138","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1097\/j.pain.0000000000003193","volume":"165","author":"PSH Smulders","year":"2024","unstructured":"Smulders, P. S. H. et al. Chemotherapy-induced peripheral neuropathy models constructed from human induced pluripotent stem cells and directly converted cells: a systematic review. Pain 165, 1914\u20131925 (2024).","journal-title":"Pain"},{"key":"1622_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14901-7","volume":"25","author":"A Sharma","year":"2025","unstructured":"Sharma, A. et al. Longitudinal multi-omics analyses of chemotherapy-induced peripheral neuropathy in response to taxanes. BMC Cancer 25, 1591 (2025).","journal-title":"BMC Cancer"},{"key":"1622_CR140","doi-asserted-by":"publisher","first-page":"1345811","DOI":"10.3389\/fnmol.2024.1345811","volume":"17","author":"X Chen","year":"2024","unstructured":"Chen, X., Gan, Y., Au, N. P. B. & Ma, C. H. E. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy. Front. Mol. Neurosci. 17, 1345811 (2024).","journal-title":"Front. Mol. Neurosci."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01622-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01622-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01622-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:03:02Z","timestamp":1778104982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01622-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01622-6","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}